Aethlon Medical Inc EBITDA margin
Quel est le EBITDA margin de Aethlon Medical Inc?
Le EBITDA margin de Aethlon Medical Inc est -951.91%
Quelle est la définition de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin des entreprises dans Industrials secteur sur NASDAQ par rapport à Aethlon Medical Inc
Que fait Aethlon Medical Inc?
the aethlon medical (nasdaq:aemd) mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. our aethlon adapt™ platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. the aethlon adapt™ product pipeline includes the hemopurifier®, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as hiv and hepatitis c.
Entreprises avec ebitda margin similaire à Aethlon Medical Inc
- Abilene Oil and Gas a EBITDA margin de -961.72%
- Plaza Centers N.V a EBITDA margin de -960.71%
- HeraMED a EBITDA margin de -959.06%
- Sealand Capital Galaxy a EBITDA margin de -957.69%
- StrikeForce Technologies a EBITDA margin de -956.58%
- Land & Homes a EBITDA margin de -955.69%
- Aethlon Medical Inc a EBITDA margin de -951.91%
- Thomson Resources Ltd a EBITDA margin de -950.96%
- Kitov Pharma Ltd a EBITDA margin de -945.60%
- Resonant Inc a EBITDA margin de -944.32%
- Microvision a EBITDA margin de -942.18%
- Cara Therapeutics Inc a EBITDA margin de -941.75%
- Torchlight Resources Inc a EBITDA margin de -933.70%